Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
sCiEnTiFiC proGrAMME<br />
Saturday 12 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 172 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
> Among 45 variants in 11 genes, HDM2 polymorphisms emerge<br />
as new candidate SNPs associated with radiation toxicity<br />
G. Alsbeih (Saudi Arabia), N. Al-Harbi, L.A. Venturina,<br />
K. Al-Hadyan, M. El-Sebaie, N. Al-Rajhi Pd-0529<br />
> Proteomic identification of putative biomarkers of radiotherapy<br />
resistance<br />
L. Scaife (United Kingdom), V.C. Hodgkinson, D. ELFadl,<br />
S. Mehmood, I.A. Hunter, G.P. Liney, A.W. Beavis, P.J. Drew,<br />
M.J. Lind, L. Cawkwell Pd-0530<br />
> SNPs in DNA repair and damage detection genes and acute<br />
normal tissue toxicity in prostate cancer patients<br />
L. Fachal (Spain), A. Gómez-Caamaño, P. Peleteiro, A. Carballo,<br />
P. Calvo-Crespo, M. Sánchez-García, B. Taboada-Valladares,<br />
R. Lobato-Busto, A. Carracedo, A. Vega Pd-0531<br />
> 64Cu-radiolabeled octreotate as a theranostic agent for cancer:<br />
role of p53 in the therapeutic response<br />
A. Chang (USA), K. Nguyen, B. Rogers, R. Laforest,<br />
C.J. Anderson Pd-0532<br />
> Pre-treatment nocturia, radical prostatectomy and TGFß1 SNPs<br />
are associated with radiation-induced nocturia<br />
S. De Langhe (Belgium), K. De Ruyck, P. Ost, V. Fonteyne,<br />
J. Werbrouck, G. De Meerleer, W. De Neve, H. Thierens Pd-0533<br />
> Major vault protein as a prognosis factor in cervical carcinoma<br />
tumours treated with radiotherapy<br />
L.A. Henríquez-Hernández (Spain), A. Valenciano, M. Lloret,<br />
B. Clavo, B. Pinar, P.C. Lara Pd-0534<br />
> Prognostic effect of RAD51 and EGFR on survivalin colorectal<br />
adenocarcinoma<br />
K. B<strong>org</strong>mann (Germany), R. Fresow, P. Tennstedt, R. Simon,<br />
A. Marx, G. Sauter, L. Terracciano, C. Petersen, E. Dikomey Pd-0535<br />
Saturday 12 May 2012<br />
abS. numbER<br />
JOINT SYMPOSIUM<br />
EsTro-EAnM: ThE FUTUrE oF rAdio-isoTopE ThErApiEs<br />
(bonE METs, Thyroid, nEUroEndoCrinE, lyMphoMA)<br />
lEaRning ObJECTivES:<br />
1. To understand the potential role of radiolabelled antibodies and target treatments<br />
in the treatment of malignancy<br />
2. To review the issues relating to dosing and timing of the pretargeting agents<br />
3. To understanding the particular issues relating to dosimetry in radiopharmaceutical<br />
treatment<br />
16:15 - 17:15 • Auditorium<br />
ChaiR: D. Hollywood (Ireland Republic of)<br />
CO-ChaiR: W. Oyen (The Netherlands)<br />
16:15 > Radium-223 in the treatment of advanced prostate cancer<br />
SPEaKER: V. Lewington (United Kingdom) SP-0536<br />
16:35 > Translational studies on pretargeted radioimmunotherapy of<br />
colorectal cancer<br />
SPEaKER: O. Boerman (The Netherlands) SP-0537<br />
16:55 > Radiolabelled somatostatin analogues in neuroendocrine tumours<br />
SPEaKER: F. Jamar (Belgium) SP-0538<br />
SYMPOSIUM<br />
EU proJECTs<br />
16:15 - 17:30 • Room 113-114<br />
ChaiR: J. Bourhis (France)<br />
16:15 > ARTFORCE Consortium: an update<br />
SPEaKER: C. Rasch (The Netherlands) SP-0539<br />
16:30 > ARTFORCE: adaptive radiotherapy<br />
SPEaKER: J. Sonke (The Netherlands) SP-0540<br />
16:45 > The ANDANTE Project: refining risk estimates from neutrons<br />
SPEaKER: A. Ottolenghi (Italy) SP-0541<br />
17:00 > The risk of second cancers following proton therapy<br />
SPEaKER: K. Trott (United Kingdom) SP-0542<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 173<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language